Trial Profile
Evaluation of florbetapir (18F) PET in subjects participating in the IRCCSFBF protocol
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 21 Nov 2016
Price :
$35
*
At a glance
- Drugs Florbetapir F 18 (Primary)
- Indications Alzheimer's disease; Dementia
- Focus Diagnostic use; Registrational
- Acronyms India-FBP
- Sponsors Avid Radiopharmaceuticals
- 31 Oct 2016 Results assessing incremental diagnostic value of florbetapir F 18 imaging ublished in the JAMA Neurology.
- 07 Apr 2014 New trial record